C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
11/2009
11/25/2009	EP2123675A2 Human EPO mimentic hinge core mimetibodies, compositions, methods and uses
11/25/2009	EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
11/25/2009	EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009	EP2121764A1 Viral polyhedra complexes and methods of use
11/25/2009	EP2121748A2 Nucleic acid, polypeptide and its use
11/25/2009	EP2121736A1 New anti-malaria vaccine compositions and uses thereof
11/25/2009	CN101588818A Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family
11/25/2009	CN101588817A Fully human high yield production system for improved antibodies and proteins
11/25/2009	CN101586113A CCK39/UreB double-fusion gene and protein coded by same and expression vector
11/25/2009	CN101585882A Fusion protein for treating breast cancer and application thereof
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622127 Clostridial toxin derivatives and methods for treating pain
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622111 Fusion protein of human IgG1 heavy chain constant region and scFv antibody against equine encephalitis virus
11/24/2009	CA2362153C Antimicrobial/endotoxin neutralizing polypeptide
11/24/2009	CA2321938C Poly zinc finger proteins with improved linkers
11/24/2009	CA2303063C Mage-3 peptides presented by hla class ii molecules
11/19/2009	WO2009140666A2 METHODS AND REAGENTS FOR DETECTING CpG METHYLATION WITH A METHYL CpG BINDING PROTEIN (MBP)
11/19/2009	WO2009139599A2 Cell-permeable p27 recombinant protein, a polynucleotide that codes the same and an anti-cancer composition containing the same as an active ingredient
11/19/2009	WO2009137911A1 Process, vectors and engineered cell lines for enhanced large-scale transfection
11/19/2009	US20090286964 Modified Fc molecules
11/19/2009	US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009	US20090286958 Interferon-beta fusion proteins and uses
11/19/2009	US20090286721 Targeted plasminogen activator fusion proteins as thromobolytic agents
11/19/2009	US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009	US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	CA2724630A1 Targeted coagulation factors and method of using the same
11/19/2009	CA2724343A1 Methods and reagents for detecting cpg methylation with a methyl cpg binding protein (mbp)
11/18/2009	EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009	EP0960127B1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
11/18/2009	CN101580548A Fusion peptide for inhibiting tumor growth and application thereof in preparing anti-tumor medicament
11/18/2009	CN101580541A Infectious pancreatic necrosis recombinant VP2 protein antigen and purification method
11/18/2009	CN101580540A Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof
11/18/2009	CN100560549C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/17/2009	US7619063 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
11/17/2009	US7619062 PRO214 polypeptides
11/17/2009	US7619061 Antigen constructs useful in the detection and differentiation of antibodies to HIV
11/17/2009	US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009	US7618818 Method for detecting leptin receptor ligands
11/17/2009	US7618628 CD16A binding proteins and use for the treatment of immune disorders
11/17/2009	CA2341429C Treatment of mucus hypersecretion
11/17/2009	CA2211459C A method for making heteromultimeric polypeptides
11/12/2009	WO2009137721A2 Lysosomal targeting peptides and uses thereof
11/12/2009	WO2009087577A3 Barb4 target which comprises tata-binding protein-associated factor 15, antibody designated barb4, barb4 related antibodies, and methods of making and using same
11/12/2009	WO2009070234A3 Complexation of fatty acid-conjugated molecules with albumin
11/12/2009	US20090281287 IL-17 receptor like molecules and uses thereof
11/12/2009	US20090281286 Modified antibodies in which thrombopoietin, angiotensin-2, nerve growth factor and/or B-cell activating factor peptides are incorporated into a loop region of a non-terminal domain; therapeutic proteins; mimetics; enhanced bioassays
11/12/2009	US20090280562 Materials and methods for preparing dimeric growth factors
11/12/2009	US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009	US20090280085 Long Acting Human Interferon Analogs
11/12/2009	CA2723412A1 Lysosomal targeting peptides and uses thereof
11/12/2009	CA2722127A1 Compositions and methods for inhibiting shiga toxin and shiga-like toxin
11/11/2009	EP2116616A2 Genes differentially expressed in activated T cells and uses thereof
11/11/2009	EP2116604A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
11/11/2009	EP2116259A1 TACI-immunoglobulin fusion proteins
11/11/2009	EP2114985A2 Multivariable antigens complexed with targeting humanized monoclonal antibody
11/11/2009	EP2114437A2 Modified corticotropin releasing factor peptides and uses thereof
11/11/2009	CN101575380A Tumor target and recombined human Fas ligand fusion protein and preparation method thereof
11/11/2009	CN101575379A Soluble VEGFR difunctional fusion receptors, preparation method and use thereof
11/11/2009	CN100558899C Growth hormone fusion protein
11/11/2009	CN100558747C Immunogen by using mutant CRM197 of diphtheria toxin as carrier, preparation method, and application
11/11/2009	CN100558395C Hybrid peptide modulate immune response
11/10/2009	US7615614 Antigen constructs useful in the detection and differentiation of antibodies to HIV
11/10/2009	US7615613 Antigen constructs useful in the detection and differentiation of antibodies to HIV
11/10/2009	US7615611 Human cytokine receptor
11/10/2009	US7615610 Arrestin chimera comprising naturally occurring beta-arrestin-2 and naturally occurring ubiquitin moiety, where arrestin chimera has increased affinity for GPCR, and where increased affinity means that arrestin chimera remains associated with and traffics with GPCR into endosomes
11/10/2009	US7615229 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2009	US7615228 Chimeric protein containing specific polypeptide and a conserved fragment of hemagglutin antigen from influenza virus
11/10/2009	US7615225 Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen
11/10/2009	US7615217 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/10/2009	CA2479476C Compositions and methods for the treatment of tumor
11/05/2009	WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009	WO2009133882A1 Bacterial toxin vaccine
11/05/2009	WO2009102782A3 Increasing efficiency of nucleic acid delivery in vivo using targeting conjugates
11/05/2009	WO2009093118A9 Cell surface display of proteins
11/05/2009	US20090275738 Use of A33 antigens and jam-it
11/05/2009	US20090275125 Human T1R2 Taste Receptor Nucleic Acids and Cells Containing These Nucleic Acids
11/05/2009	US20090274718 Chimeric proteins that induce effects directed against viruses
11/05/2009	US20090274708 Recombinant Toxin Fragments
11/05/2009	US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009	CA2725601A1 Supercharged proteins for cell penetration
11/05/2009	CA2722797A1 Fusion molecules of rationally-designed dna-binding proteins and effector domains
11/04/2009	EP1700913B1 Fluorescent proteins
11/04/2009	EP1375664B1 Method for the secretion and production of protein
11/04/2009	EP1098910B1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
11/03/2009	US7612190 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy
11/03/2009	US7611832 Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
11/03/2009	US7611721 Adjuvant combination formulations
11/03/2009	CA2191064C Pantropic neurotrophic factors
10/2009
10/29/2009	WO2009130612A2 Prion epitopes and methods of use thereof
10/29/2009	US20090269843 Hemopexin fusion proteins
10/29/2009	CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus
10/29/2009	CA2721833A1 Prion epitopes and methods of use thereof
10/28/2009	EP2111230A2 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
10/28/2009	EP1888625B1 Malaria vaccines
10/28/2009	EP1436003B1 Taci-immunoglobulin fusion proteins
10/27/2009	US7608686 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
10/27/2009	US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules

1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 295